Detection of germ-cell tumor cells in the peripheral blood by nested reverse transcription-polymerase chain reaction for α-fetoprotein-messenger RNA and β human chorionic gonadotropin-messenger RNA

Cancer Research

Volumn 60, Issue 12, 2000, Pages 3170-3174

  Hautkappe, Andreas L A ^a,b   Lu, Mengji ^b   Mueller, Hendrik ^b   Bex, Axel ^b   Harstrick, Andreas ^b   Roggendorf, Michael ^b   Ruebben, Herbert ^b  

^a UNIVERSITY OF ESSEN MEDICAL SCHOOL   (Germany)

^b UNIVERSITY OF DUISBURG ESSEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA FETOPROTEIN; CHORIONIC GONADOTROPIN BETA SUBUNIT; MESSENGER RNA;

ARTICLE; CANCER DIAGNOSIS; CANCER STAGING; CONTROLLED STUDY; CORRELATION FUNCTION; EMBRYONAL CARCINOMA; GERM CELL TUMOR; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN DETERMINATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ANALYSIS;

ADOLESCENT; ADULT; ALPHA-FETOPROTEINS; CASE-CONTROL STUDIES; CHORIONIC GONADOTROPIN, BETA SUBUNIT, HUMAN; GERMINOMA; HUMANS; LEUKOCYTES, MONONUCLEAR; MALE; MIDDLE AGED; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SEMINOMA; TESTICULAR NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 0034124451     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Mann, K., Saller, B., and Hoermann, R. Clinical use of hCG and hCG/3 determination. Scand. J. Clin. Lab. Invest., 53 (Suppl. 216): 97-104, 1993.
2. Saller, B., Clara, R., Spöttl, G., Siddl, K., and Mann, K. Testicular cancer secretes intact human choriongonadotropin (hCG) and its free β-subunits: evidence that hCG (+ hCG-β) assays are the most reliable in diagnosis and follow-up. Clin. Chem., 36, 2: 234-239, 1990.
3. Barzell, W. E., and Whitmore, W. F. Jr. Clinical significance of biological markers: Memorial Hospital experience. Semin. Oncol., 6: 48-52, 1979.
4. Fraley, E. E., Lange, P. H., and Kennedy, B. J. Germ-cell testicular cancer in adults. N. Engl. J. Med., 301: 1370-1377 and 1420-1426, 1979.
5. Javadpour, N. The role of biologic tumor markers in testicular cancer. Cancer (Phila.), 45: 1755-1761, 1980.
6. Whishnow, K. I., Johnson, D. E., Swanson, D. A., Tenney, D. M., Babaian, R. J., Dunphy, C. H., Ayala, A. G., Ro, J. Y., and von Eschenbach, A. C. Identifying patients with low-risk clinical stage I nonseminomatous testicular tumors who should be treated by surveillance. Urology. 34: 339-334, 1989.
7. Klepp, O., Olsson, A. M., Henrikson, H., Aass, N., Dahl, O., Stenwig, A. E., Persson, B. E., Cavallin-Stahl, E., Fossa, S. D., and Wahlqvist, L. Prognostic factors in clinical stage I non-seminomatous germ cell tumors of the testis: multivariate analysis of a prospective multicenter study. J. Clin. Oncol., 8: 509-518, 1990.
8. Cama, C., Olsson, C. A., Raffo, A. J., Perlman, H., Buttyan, R., O'Toole, K., McMahon, D., Benson, M. C., and Katz, A. E. Molecular staging of prostate cancer. A comparison of the application of an enhanced reverse transcriptase polymerase chain reaction assay for prostate specific antigen versus prostate specific membrane antigen. J. Urol., 153: 1373-1378, 1995.
9. Israeli, R. I., Miller, W. H., Jr., Su, S. L., Powell, C. T., Fair, W. R., Samadi, D. S., Huryk, R. F., DeBlasio, A., Edwards, E. T., Wise, G. J., and Heston, W. D. W. Sensitive nested reverse transcription polymerase chain reaction detection of circulating prostatic tumor cells: comparison of prostate specific antigen and prostate specific antigen-based assay. Cancer Res., 54: 6306-6310, 1994.
10. Katz, A. E., Olsson, C. A., Raffo, A. J., Cama, C., Perlman, H., Seaman, E., O'Toole, K. M., McMahon, D., Benson, M. C., and Buttyan, R. Molecular staging of prostate cancer with the use of an enhanced reverse transcriptase assay. Urology, 43: 765-775, 1994.
11. Seiden, M. V., Kantoff, P. W., Krithivas, K., Propert, K., Bryant, M., Haltom, E., Gaynes, L., Kaplan, I., Bubley, C., and DeWolf, W. Detection of circulating tumor cells in men with localized prostate cancer. J. Clin. Oncol., 12: 2634-2639, 1994.
12. Funaki, N., Tanaka, J., Seto, S., Kasamalsu, T., Kaido, T., and Imamura, M. Highly-sensitive identification of α-fetoprotein-mRNA in circulating peripheral blood of hepatocellular carcinoma patients. Life Sci., 57: 1621-1631, 1995.
13. Komeda, T., Fukuda, Y., Sando, T., Kita, R., Furukawa, M., Nishida, N., Amenomori, M., and Nakao, K. Sensitive detection of circulating hepatocellular carcinoma cells in peripheral venous blood. Cancer (Phila.), 75: 2214-2219, 1995.
14. Hoon, D. S. B., Sarantou, T., Doi, F., Chi, D. D., Kuo, C., Conrad, A. J., Schmid, P., Turner, R., and Guiliano, A. Detection of melastatic breast cancer by β-hCG polymerase chain reaction. Int. J. Cancer, 69: 369-374, 1996.
15. Berger, P., Kranewitter, W., Madersbacher, S., Gerth, R., Geley, S., and Dirnhofer, S. Eutopic production of human chorionic gonadotropin β (hCGβ) and luteinizing hormone β (hLHβ) in human testis. FEBS Lett., 343: 229-233, 1994.
16. Madersbacher, S., Kratzik, C., Gerth, R., Dirnhofer, S., and Berger, P. Human chorionic gonadotropin (hCG) and its free subunits in hydrocele fluids and neoplastic tissue of teslicular cancer patients: insight into the in vivo hCG secretion pattern. Cancer Res., 54: 5096-5100, 1994.
17. Yuasa, T., Yoshiki, T., Ogawa, O., Tanaka, T., Isono, T., Mishina, M., Higuchi, K., Okada, Y., and Yoshida, O. Detection of α-fetoprotein-mRNA in seminoma. J. Androl., 20: 336-340, 1999.
18. Sharpe, P. T. Methods of cell separation. In: R. H. Burdon and van Knippenberg (eds.). Laboratory Techniques in Biochemistry and Molecular Biology, pp. 107-142. Amsterdam: Elsevier, 1988.
19. Mastsumura M., Niwa, Y., Hikiba, Y., Okano, K., Kato, N., Shiina, S., Shiratori, Y., and Omata, M. Sensitive detection of hepatocellular carcinoma associated gene transcription (α-fetoprotein-mRNA) in blood. Biochem. Biophys. Res. Comm., 202: 813-818, 1995.
20. Boorstein, W. R., Vamvakopoulos, N. C., and Fiddes, J. C. Human Chorionic gonadotropin β-subunit is encoded by at least eight genes arranged in tandem and inverted pairs. Nature (Lond.), 300: 419-422, 1982.
21. Bo, M., and Boime, I. Identification of transcriptionally active genes of the chorionic gonadotropin β gene cluster in vivo. J. Biol. Chem., 267: 3179-3184, 1992.
22. International Germ Cell Cancer Collaborative Group. International germ cell consensus classification: a prognostic factor-based staging system for metastatic germ cell cancers. J. Clin. Oncol., 15: 594-603, 1997.
23. Hoon, D. S. B., Wang, Y., Dale, P. S., Conrad, A. J., Schmid, P., Garrison, D., Kuo, C., Foshag, L. J., Nizze, A. J., and Morton, D. L. Detection of occult melanoma cells in blood with a multiple-marker polymerase chain reaction assay. J. Clin. Oncol., 13: 8: 2109-2116, 1995.
24. Funaki, N. O., Tanaka, J., Seto, S. I., Kasamatsu, T., Kaido, T., and Imamura, M. Hematogenous spreading of hepatocellular carcinoma cells: possible participation in recurrence in the liver. Hepatology, 25: 564-568, 1997.
25. Fan, Y., Einhorn, L., Saxman, S., Katz, B., Abonour, R., and Cometta, K. Detection of germ cell tumor cells in apheresis products using polymerase chain reaction. Clin. Cancer Res., 4: 93-98, 1998.
26. Wong, I. H., Leung, T., Ho, S., Lau, W. Y., Chan, M., and Johnson, P. J. Semiquantification of circulating hepatocellular carcinoma cells by reverse transcriptase polymerase chain reaction. Br. J. Cancer, 76: 628-633, 1997.
27. Sogagni, P. C., Perrotti, M., Herr, H. W., Fair, W. R., Thaler, H. T., and Bosl, G. Clinical stage I testis cancer: long-term outcome of patients on surveillance. J. Urol., 159: 855-858, 1998.
28. Weißbach, L., Bamberg, M., Schmoll, H. J. Interdisziplinäre Konsensuskonferenz zur Diagnostik und Therapie von Hodentumoren. Urologe A., 36: 362-368, 1997.